FDG PET/MR Imaging in Major Neurocognitive Disorders

Area of Science:

• Medical Imaging
• Neuroscience
• Molecular Imaging

Background:

• Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) are crucial for assessing neurodegenerative diseases.
• Integrated PET/MRI represents a significant advancement in hybrid molecular imaging.
• Neurodegenerative disorders, including major neurocognitive disorders (dementias), are a key focus for this technology.

Purpose of the Study:

• To review current evidence on the use of integrated PET/MRI in neurodegenerative conditions.
• To explore the potential of PET/MRI in diagnosing and monitoring dementias.
• To address challenges and future directions for PET/MRI in neuroimaging.

Main Methods:

• Review of existing studies utilizing integrated PET/MRI scanners for neurodegenerative conditions.
• Analysis of comparative performance against standalone PET/CT and MRI.
• Discussion of quantitative challenges (attenuation, partial volume, motion correction) and semi-quantitative analysis for FDG PET.

Main Results:

• The number of PET/MRI studies in neurodegeneration is currently limited.
• PET/MRI results are generally comparable to those obtained from separate PET/CT and MRI acquisitions.
• Challenges in quantitative PET/MRI analysis, such as corrections and semi-quantitative approaches, are identified.

Conclusions:

• Integrated PET/MRI shows promise for neurodegenerative disorder assessment, comparable to current standards.
• Future developments in PET tracers (amyloid, tau) suggest PET/MRI could become the preferred method for single-session, multi-modal neuroimaging.
• Addressing quantitative challenges is crucial for maximizing the clinical utility of PET/MRI in dementia evaluation.